Sign in
Not yet recruitingNo phase

Integrated Medicine for Sepsis: An RCT With Phenotyping

Key facts

Who runs it
Henan University of Traditional Chinese Medicine
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
320 people, planned
Started
2 Nov 2026
Expected to end
31 Dec 2029
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Syndrome-Differentiated Chinese Herbal Medicine
  • Matching Placebo for Syndrome-Differentiated Chinese Herbal Medicine
Record updated
6 November 2026

Who can take part

Age
18 years to 79 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age ≥18 years and <80 years
  • Meeting the Sepsis-3.0 definition and diagnostic criteria for sepsis, with a Sequential Organ Failure Assessment (SOFA) score of 2-13
  • Patients with pulmonary infection or bloodstream infection
  • Meeting the diagnostic criteria for one of the following traditional Chinese medicine syndrome patterns: phlegm-heat obstructing the lung syndrome, exuberant heat-toxin syndrome, Yangming bowel excess syndrome, or stasis-toxin obstructing the collaterals syndrome
  • Written informed consent provided by the patient or the patient's legally authorized representative/family member

Who cannot take part

  • Use of immunosuppressive therapy or receipt of organ transplantation within the previous 3 months
  • Participation in another interventional drug clinical trial within 1 month prior to enrollment
  • Patients with severe underlying diseases, including unresectable malignancies, hematologic diseases, or human immunodeficiency virus (HIV) infection
  • Known allergy or hypersensitivity to any of the study medications
  • Patients with trauma, including fractures, burns, hepatic rupture, splenic rupture, or other major traumatic injuries
  • Pregnant or breastfeeding women
  • Severe hepatic or renal dysfunction, defined as a score ≥3 in the hepatic or renal component of the SOFA score

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 79 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the clinical efficacy and safety of integrated traditional Chinese and Western medicine in the treatment of sepsis, explore its potential value in improving clinical outcomes, and provide high-quality clinical evidence for the integrated management of sepsis.In addition, blood samples will be collected for phenotyping and subsequent transcriptomic, proteomic, and metabolomic analyses.

The 2 groups in the trial

  • Standard Western Medicine Plus Syndrome-Differentiated Chinese Herbal MedicineTreatment being tested

    Participants will receive standard Western medical treatment for sepsis in combination with syndrome-differentiated Chinese herbal medicine according to the study protocol.

    Treatment: Syndrome-Differentiated Chinese Herbal Medicine

  • Standard Western Medicine Plus Matching PlaceboPlacebo, for comparison

    Participants will receive standard Western medical treatment for sepsis in combination with a matching placebo of the syndrome-differentiated Chinese herbal medicine according to the study protocol.

    Treatment: Matching Placebo for Syndrome-Differentiated Chinese Herbal Medicine

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy of Integrated Chinese and Western Medicine for Sepsis With Phenotypic Profiling: A Randomized Controlled Trial
Criteria questions
Built from NCT07920692, who can take part
Record updated
6 November 2026
Integrated Medicine for Sepsis: An RCT With Phenotyping (NCT07920692) – Frontlight Research